Novo Holdings A/S Q2 2018 Filing

Filed August 14, 2018

Portfolio Value

$991.1B

Holdings

18

Report Date

Q2 2018

Filing Type

13F-HR

All Holdings (18 positions)

#StockSharesValue% PortfolioType
1
INGNINOGEN INC
3,549,320$661.3B66.73%
2
XLRNACCELERON PHARMA INC
1,103,937$53.6B5.40%
3
CRVSCORVUS PHARMACEUTICALS INC
4,420,516$48.5B4.90%
4
MRUSMERUS N V
1,410,417$32.1B3.24%
5
AKBAAKEBIA THERAPEUTICS INC
3,100,000$30.9B3.12%
6
GKOSGLAUKOS CORP
602,709$24.5B2.47%
7
DERMIRA INC
1,993,746$18.3B1.85%
8
KIDSORTHOPEDIATRICS CORP
653,349$17.4B1.76%
9
AM6AMICUS THERAPEUTICS INC
1,081,181$16.9B1.70%
10
RA PHARMACEUTICALS INC
1,465,838$14.6B1.47%
11
SPNEUSDSEASPINE HLDGS CORP
927,788$11.7B1.18%
12
MENLO THERAPEUTICS INC
1,436,313$11.7B1.18%
13
VRNAVERONA PHARMA PLC
740,740$10.1B1.02%
14
NABRIVA THERAPEUTICS PLC
2,888,720$10.1B1.01%
15
UNUM THERAPEUTICS INC
665,181$9.5B0.96%
16
AERIEURAERIE PHARMACEUTICALS INC
126,397$8.5B0.86%
17
WRIGHT MED GROUP N V
4,622,032$5.9B0.60%
18
INVUITY INC
1,363,848$5.3B0.54%